Latest Breaking News On - Company or scisparc - Page 1 : vimarsana.com

SciSparc Secures Strategic Advantage with Grant of European Patent

TEL AVIV, Israel, May 31, 2024 SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central.

United statesTrademark officeScisparc ltdEuropean patent officeCompany or scisparcExchange commissionWorld health organizationUnited states patentTourette syndromeLooking statementsPrivate securities litigation reform actAnnual report

SciSparc Ltd: SciSparc to Acquire AutoMax

SciSparc Ltd: SciSparc to Acquire AutoMax
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDennis riedlMichal efratyAmitai weissExchange commissionAutomax ltdScisparc ltdCompany or scisparcDelhom automax ltdAutomax motors ltdAutomax motorsCombined companyTourette syndromeDelhom automaxAutomax trade inInformation about

SciSparc (SPRC) to Acquire AutoMax

SciSparc (SPRC) to Acquire AutoMax
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amitai weissAutomax motors ltdScisparc ltdCompany or scisparcAutomax motorsCombined company

SciSparc to Acquire AutoMax

SciSparc to Acquire AutoMax
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichal efratyAmitai weissAutomax ltdExchange commissionDelhom automax ltdCompany or scisparcAutomax motors ltdScisparc ltdAutomax motorsCombined companyTourette syndromeDelhom automaxAutomax trade inInformation aboutUnited states securities

SciSparc : MitoCareX Update - Form 6-K -March 13, 2024 at 09:09 am EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer .

United statesTel avivOz adlerScisparc ltdMitocarex bio ltdCompany or scisparcSecurities exchangeExchange commissionForeign private issuerSecurities exchange actWallenberg streetMitocarex bioAlon silbermanPrivate securities litigation reform actAnnual reportExecutive officer